OCUGEN, INC. Accrued Liabilities, Current
OCUGEN, INC. (OCGN) had Accrued Liabilities, Current of $9.90 million as of 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2023-02-28
- 2022-12-31: Accrued Liabilities, Current $9.90M.
- 2022-09-30: Accrued Liabilities, Current $8.00M.
- 2022-06-30: Accrued Liabilities, Current $4.10M.
- 2022-03-31: Accrued Liabilities, Current $3.54M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2022-12-31 | $9.90M 10-K · filed 2023-02-28 | |
| 2022-09-30 | $8.00M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $4.10M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $3.54M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $4.33M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $2.93M 10-K · filed 2021-03-19 | |
| 2020-09-30 | $2.33M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $2.08M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.38M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $2.27M 10-K · filed 2021-03-19 | |
| 2019-09-30 | $1.30M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.16M 8-K/A · filed 2019-10-07 | $253.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $99.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $1.40M 10-K · filed 2020-03-27 | $1.00M 10-K · filed 2019-03-22 |
| 2018-09-30 | $1.97M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.67M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $1.74M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $2.71M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $1.52M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.39M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $995.00K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $2.10M 10-K · filed 2018-03-15 | |
| 2015-12-31 | $1.44M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $2.45M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $2.09M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $1.90M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $1.68M 10-K · filed 2016-03-10 | $1.68M 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |